Literature DB >> 25187566

Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling.

Christian M Hedrich1, Thomas Rauen2, Sokratis A Apostolidis3, Alexandros P Grammatikos3, Noe Rodriguez Rodriguez3, Christina Ioannidis3, Vasileios C Kyttaris3, Jose C Crispin3, George C Tsokos4.   

Abstract

The immune-regulatory cytokine IL-10 plays a central role during innate and adaptive immune responses. IL-10 is elevated in the serum and tissues of patients with systemic lupus erythematosus (SLE), an autoimmune disorder characterized by autoantibody production, immune-complex formation, and altered cytokine expression. Because of its B cell-promoting effects, IL-10 may contribute to autoantibody production and tissue damage in SLE. We aimed to determine molecular events governing T cell-derived IL-10 expression in health and disease. We link reduced DNA methylation of the IL10 gene with increased recruitment of Stat family transcription factors. Stat3 and Stat5 recruitment to the IL10 promoter and an intronic enhancer regulate gene expression. Both Stat3 and Stat5 mediate trans-activation and epigenetic remodeling of IL10 through their interaction with the histone acetyltransferase p300. In T cells from SLE patients, activation of Stat3 is increased, resulting in enhanced recruitment to regulatory regions and competitive replacement of Stat5, subsequently promoting IL-10 expression. A complete understanding of the molecular events governing cytokine expression will provide new treatment options in autoimmune disorders, including SLE. The observation that altered activation of Stat3 influences IL-10 expression in T cells from SLE patients offers molecular targets in the search for novel target-directed treatment options.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187566      PMCID: PMC4169908          DOI: 10.1073/pnas.1408023111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.

Authors:  P Enghard; D Langnickel; G Riemekasten
Journal:  Scand J Rheumatol       Date:  2006 May-Jun       Impact factor: 3.641

3.  The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus.

Authors:  Kazue Tsuji-Takayama; Motoyuki Suzuki; Mayuko Yamamoto; Akira Harashima; Ayumi Okochi; Takeshi Otani; Toshiya Inoue; Akira Sugimoto; Terumasa Toraya; Makoto Takeuchi; Fumiyuki Yamasaki; Shuji Nakamura; Masayoshi Kibata
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

4.  p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.

Authors:  E Pfitzner; R Jähne; M Wissler; E Stoecklin; B Groner
Journal:  Mol Endocrinol       Date:  1998-10

5.  Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells.

Authors:  L R Grant; Z-J Yao; C M Hedrich; F Wang; A Moorthy; K Wilson; D Ranatunga; J H Bream
Journal:  Genes Immun       Date:  2008-04-10       Impact factor: 2.676

Review 6.  Th17 cells: a new fate for differentiating helper T cells.

Authors:  Zhi Chen; John J O'Shea
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

7.  Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration.

Authors:  Tatsuhiro Harada; Vasileios Kyttaris; Yansong Li; Yuang-Taung Juang; Ying Wang; George C Tsokos
Journal:  Autoimmunity       Date:  2007-02       Impact factor: 2.815

Review 8.  Transcriptional regulation of IL-2 in health and autoimmunity.

Authors:  José C Crispín; George C Tsokos
Journal:  Autoimmun Rev       Date:  2008-08-24       Impact factor: 9.754

9.  Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.

Authors:  Susana Mellor-Pita; Maria J Citores; Raquel Castejon; Miguel Yebra-Bango; Pablo Tutor-Ureta; Silvia Rosado; Jose L Andreu; Juan A Vargas
Journal:  Cytometry B Clin Cytom       Date:  2009-07       Impact factor: 3.058

10.  Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Matthias Kretzler; Anne Davidson
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more
  64 in total

Review 1.  Novel Treatments in Lupus.

Authors:  Vasileios C Kyttaris
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

2.  CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.

Authors:  Brian C Betts; Elizabeth M Sagatys; Anandharaman Veerapathran; Mark C Lloyd; Francisca Beato; Harshani R Lawrence; Binglin Yue; Jongphil Kim; Said M Sebti; Claudio Anasetti; Joseph Pidala
Journal:  J Leukoc Biol       Date:  2015-02-06       Impact factor: 4.962

Review 3.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

4.  Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.

Authors:  Shih-Yao Chen; Ming-Fei Liu; Pin-Yu Kuo; Chrong-Reen Wang
Journal:  Clin Rheumatol       Date:  2019-02-15       Impact factor: 2.980

5.  Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients.

Authors:  Jun Liu; Feng-Hong Chen; Shu-Qi Qiu; Li-Tao Yang; Huan-Ping Zhang; Jiang-Qi Liu; Xiao-Rui Geng; Gui Yang; Zhi-Qiang Liu; Jing Li; Zhi-Gang Liu; Hua-Bin Li; Ping-Chang Yang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

6.  CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.

Authors:  Shi Yong Neo; Ying Yang; Julien Record; Ran Ma; Xinsong Chen; Ziqing Chen; Nicholas P Tobin; Emily Blake; Christina Seitz; Ron Thomas; Arnika Kathleen Wagner; John Andersson; Jana de Boniface; Jonas Bergh; Shannon Murray; Evren Alici; Richard Childs; Martin Johansson; Lisa S Westerberg; Felix Haglund; Johan Hartman; Andreas Lundqvist
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

7.  Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.

Authors:  David M Woods; Rupal Ramakrishnan; Andressa S Laino; Anders Berglund; Kelly Walton; Brian C Betts; Jeffrey S Weber
Journal:  Clin Cancer Res       Date:  2018-08-21       Impact factor: 12.531

8.  DNA methylation changes on immune cells in Systemic Lupus Erythematosus.

Authors:  Carolina Hurtado; Liliana Yazmín Acevedo Sáenz; Elsa María Vásquez Trespalacios; Rodrigo Urrego; Scott Jenks; Iñaki Sanz; Gloria Vásquez
Journal:  Autoimmunity       Date:  2020-02-04       Impact factor: 2.815

9.  IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.

Authors:  S Drennan; A D'Avola; Y Gao; C Weigel; E Chrysostomou; A J Steele; T Zenz; C Plass; P W Johnson; A P Williams; G Packham; F K Stevenson; C C Oakes; F Forconi
Journal:  Leukemia       Date:  2016-11-28       Impact factor: 11.528

Review 10.  Updates in Lupus Genetics.

Authors:  Yun Deng; Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2017-10-05       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.